Compare

Diploma /£DPLM

1D1W1M3M6MYTD1Y5YMAX

About Diploma

Diploma PLC is a UK-based international group of businesses supplying specialized technical products and services. Operating primarily in the Life Sciences, Seals, and Controls sectors, the company distributes a diversified range of products across industries such as healthcare, environmental, and industrial technology. Founded in 1931, Diploma PLC is listed on the London Stock Exchange under the ticker symbol DPLM.
Ticker
£DPLM
Primary listing
LSE
Employees
3,400

Diploma Metrics

BasicAdvanced
£9.8B
52.10
£1.41
0.92
£0.63
0.86%

What the Analysts think about Diploma

Analyst ratings (Buy, Hold, Sell) for Diploma stock.
Analyst projections of the future price of Diploma stock.

Bulls say / Bears say

Diploma reported 15% organic growth over the first nine months and raised FY26 organic growth guidance to 14%, with its expected operating margin also lifted to about 26.5%. Repeated upgrades point to strong near-term trading momentum. (Diploma PLC)
Controls has strong exposure to aerospace, defence, data centres and energy, and delivered 26% organic growth in the first half. The company said its Controls businesses continued to grow strongly in the third quarter, supporting a structural-growth case beyond general industrial demand. (Diploma PLC, Diploma PLC)
The acquisition programme offers another growth channel: 15 businesses acquired or agreed in the year to the half-year were expected to add about £40m of annualised operating profit, while Diploma reported a healthy pipeline and balance-sheet headroom. Its leverage was 0.8 times at the half-year, leaving capacity to pursue further deals. (Diploma PLC, Diploma PLC)
Management said growth is likely to moderate towards more normal levels after this unusually strong year, while margins should ease as the group reinvests and adjusts Peerless pricing. That creates a risk that profit growth slows after FY26’s sharp step-up. (StockAnalysis)
Not all divisions are sharing the Controls boom: Life Sciences faces tough healthcare markets and management expected only low single-digit growth for the year, while International Seals remained patchy. Continued weakness in these areas could limit the benefit of Diploma’s diversified portfolio. (Diploma PLC, Seeking Alpha)
The shares’ valuation leaves less room for disappointment: RBC described the rating as high and its 8,000p target implied only about 3% upside at the price then prevailing. With the share-price run already strong, further gains may need to come mainly from earnings delivery rather than a higher valuation multiple. (Proactive Investors)
Data summarised monthly by Lightyear AI. Last updated on 20 Oct 2026.

Diploma Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Diploma Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.